Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters

Lung. 2017 Oct;195(5):653-660. doi: 10.1007/s00408-017-0032-3. Epub 2017 Jun 27.

Abstract

Background: The usefulness of clinical, radiological and pleural fluid analytical parameters for diagnosing malignant and paramalignant pleural effusion is not clearly stated. Hence this study aimed to identify possible predictor variables of diagnosing malignancy in pleural effusion of unknown aetiology.

Methods: Clinical, radiological and pleural fluid analytical parameters were obtained from consecutive patients who had suffered pleural effusion of unknown aetiology. They were classified into three groups according to their final diagnosis: malignant, paramalignant and benign pleural effusion. The CHAID (Chi-square automatic interaction detector) methodology was used to estimate the implication of the clinical, radiological and analytical variables in daily practice through decision trees.

Results: Of 71 patients, malignant (n = 31), paramalignant (n = 15) and benign (n = 25), smoking habit, dyspnoea, weight loss, radiological characteristics (mass, node, adenopathies and pleural thickening) and pleural fluid analytical parameters (pH and glucose) distinguished malignant and paramalignant pleural effusions (all with a p < 0.05). Decision tree 1 classified 77.8% of malignant and paramalignant pleural effusions in step 2. Decision tree 2 classified 83.3% of malignant pleural effusions in step 2, 73.3% of paramalignant pleural effusions and 91.7% of benign ones.

Conclusions: The data herein suggest that the identified predictor values applied to tree diagrams, which required no extraordinary measures, have a higher rate of correct identification of malignant, paramalignant and benign effusions when compared to techniques available today and proved most useful for usual clinical practice. Future studies are still needed to further improve the classification of patients.

Keywords: Cancer; Diagnosis; Effusion; Malignant; Pleural effusion.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asbestosis / complications
  • Asbestosis / diagnosis*
  • Body Fluids / chemistry
  • Breast Neoplasms / complications
  • Breast Neoplasms / diagnosis
  • Decision Trees
  • Diagnosis, Differential
  • Dyspnea / epidemiology
  • Female
  • Glucose / analysis
  • Heart Failure / complications
  • Heart Failure / diagnosis*
  • Humans
  • Hydrogen-Ion Concentration
  • L-Lactate Dehydrogenase / analysis
  • Lung Neoplasms / complications
  • Lung Neoplasms / diagnosis
  • Lymphadenopathy / diagnostic imaging
  • Lymphadenopathy / epidemiology
  • Lymphoma / complications
  • Lymphoma / diagnosis
  • Male
  • Mediastinum / diagnostic imaging
  • Mesothelioma / complications
  • Mesothelioma / diagnosis
  • Neoplasms / complications
  • Neoplasms / diagnosis*
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / diagnosis
  • Pleural Effusion / diagnosis
  • Pleural Effusion / diagnostic imaging
  • Pleural Effusion / epidemiology
  • Pleural Effusion / etiology
  • Pleural Effusion, Malignant / diagnosis*
  • Pleural Effusion, Malignant / diagnostic imaging
  • Pleural Effusion, Malignant / epidemiology
  • Pleural Effusion, Malignant / etiology
  • Pleural Neoplasms / complications
  • Pleural Neoplasms / diagnosis
  • Prospective Studies
  • Pulmonary Atelectasis / diagnostic imaging
  • Pulmonary Atelectasis / epidemiology
  • Radiography, Thoracic
  • Smoking / epidemiology
  • Solitary Pulmonary Nodule / diagnostic imaging
  • Solitary Pulmonary Nodule / epidemiology
  • Thoracentesis
  • Tomography, X-Ray Computed
  • Tuberculosis, Pleural / complications
  • Tuberculosis, Pleural / diagnosis*
  • Weight Loss

Substances

  • L-Lactate Dehydrogenase
  • Glucose